Research
Risk of cardiovascular serious adverse events associated with varenicline use for tobacco cessation: systematic review and meta-analysis
BMJ 2012; 344 doi: https://doi.org/10.1136/bmj.e2856 (Published 04 May 2012) Cite this as: BMJ 2012;344:e2856Related articles
- Research Published: 06 December 2010; BMJ 341 doi:10.1136/bmj.c6549
- Paper Published: 24 June 2004; BMJ 328 doi:10.1136/bmj.38142.554479.AE
- PAPERS Published: 22 June 2004; BMJ doi:10.1136/bmj.38142.554479.AE
- Education And Debate Published: 04 September 2003; BMJ 327 doi:10.1136/bmj.327.7414.557
- Editorial Published: 08 November 2012; BMJ 345 doi:10.1136/bmj.e7547
- Research Published: 08 November 2012; BMJ 345 doi:10.1136/bmj.e7176
- Letter Published: 12 June 2012; BMJ 344 doi:10.1136/bmj.e3873
- Research Published: 12 March 2015; BMJ 350 doi:10.1136/bmj.h1109
See more
- Sixty seconds on . . . 10 000 stepsBMJ March 08, 2024, 384 q598; DOI: https://doi.org/10.1136/bmj.q598
- Scarlett McNally: Enabling active travel can improve the UK’s healthBMJ March 06, 2024, 384 q522; DOI: https://doi.org/10.1136/bmj.q522
- Scarlett McNally: Boosting swimming for health and joyBMJ February 20, 2024, 384 q393; DOI: https://doi.org/10.1136/bmj.q393
- Variability in blood pressure could help predict heart attack and stroke risk, researchers sayBMJ February 09, 2024, 384 q363; DOI: https://doi.org/10.1136/bmj.q363
- Scarlett McNally: Preventing obesity is different from curing it—and even more urgentBMJ January 23, 2024, 384 q134; DOI: https://doi.org/10.1136/bmj.q134
Cited by...
- 2018 ACC Expert Consensus Decision Pathway on Tobacco Cessation Treatment: A Report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents
- Reprint of: Prevention and Treatment of Tobacco Use: JACC Health Promotion Series
- Prevention and Treatment of Tobacco Use: JACC Health Promotion Series
- Smoking abstinence 1 year after acute coronary syndrome: follow-up from a randomized controlled trial of varenicline in patients admitted to hospital
- Interventions for smoking cessation in patients admitted with Acute Coronary Syndrome: a review
- Cardiovascular and neuropsychiatric risks of varenicline and bupropion in smokers with chronic obstructive pulmonary disease
- 2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
- 2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
- Efficacy and Safety of Smoking Cessation Interventions in Patients With Cardiovascular Disease: A Network Meta-Analysis of Randomized Controlled Trials
- Smoking Cessation, Version 1.2016, NCCN Clinical Practice Guidelines in Oncology
- Varenicline and Adverse Cardiovascular Events: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
- Varenicline for Smoking Cessation in Hospitalized Patients With Acute Coronary Syndrome
- What are the effects of varenicline compared with nicotine replacement therapy on long-term smoking cessation and clinically important outcomes? Protocol for a prospective cohort study
- Risk of neuropsychiatric adverse events associated with varenicline: systematic review and meta-analysis
- Cardiovascular and neuropsychiatric safety of varenicline and bupropion compared with nicotine replacement therapy for smoking cessation: study protocol of a retrospective cohort study using the QResearch general practice database
- Cardiovascular Events Associated With Smoking Cessation Pharmacotherapies: A Network Meta-Analysis
- Does smoking cessation with varenicline worsen vascular endothelial function?
- Smoking cessation and COPD
- Choice of summary statistics: relative and absolute measures
- Smoking Cessation After Acute Myocardial Infarction
- Bupropion for Smoking Cessation in Patients Hospitalized With Acute Myocardial Infarction: A Randomized, Placebo-Controlled Trial
- Varenicline for smoking cessation
- Use of varenicline for smoking cessation and risk of serious cardiovascular events: nationwide cohort study
- Flaws in analysis lead to misleading conclusions about varenicline's safety in smoking cessation
- Authors' reply to Singh and Loke
- Cardiovascular Risk Doesn't Increase During Varenicline Use for Tobacco Cessation